Lanzamiento Enero 2027

Ensayo controlado aleatorizado2026Alimentación controlada

Betainized metabolites as biomarkers of whole grain wheat, not oat: insights from controlled crossover pharmacokinetic and daily feeding studies

Li Y, Novotny JA, Baer D, Hu Y, Sun Q, Zhang S, Sang S

The American journal of clinical nutrition · 1 cita

Etiquetas de revisión

Alimentación controlada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Sin resultado de salud
Consumo medido con
Comida provista por los investigadores

Quién lo pagó

Financiación
Financiación independiente
Gobierno
National Institute of Food and Agriculture
Subvenciones
National Institute of Food and Agriculture (2018–67001-28265)

Según 1 financiador declarado.

Publicación

Publicado
2025-12-19 · Am J Clin Nutr · vol. 123 · número 2 · pág. 101139
Editorial
Elsevier BV
Citado
0 citas · más que el 46% de estudios similares · 0.0× el promedio de su campo
Referencias
50 trabajos
Acceso
De pago
Áreas de investigación
Food composition and properties · Phytochemicals and Antioxidant Activities · Seed and Plant Biochemistry
Palabras clave
whole wheat, whole grain oats, one-carbon metabolism, osmoprotection, pharmacokinetics, urinary excretion, personalized nutrition, plasma accumulation, interindividual variability
MeSH
humans, triticum, betaine, valine, diet, cross-over studies, adult, middle aged, female, male, young adult, biomarkers, avena, whole grains

7 autores

  • Yanhe Li🇺🇸North Carolina Agricultural and Technical State University
  • Janet A Novotny🇺🇸Agricultural Research Service; United States Department of Agriculture; Beltsville Human Nutrition Research Center
  • David Baer🇺🇸Agricultural Research Service; United States Department of Agriculture; Beltsville Human Nutrition Research Center
  • Yang Hu🇺🇸Harvard University
  • Qi Sun🇺🇸Brigham and Women's Hospital; Harvard University
  • Shuwei Zhang🇺🇸North Carolina Agricultural and Technical State University
  • Shengmin Sang🇺🇸 · autor de correspondenciaNorth Carolina Agricultural and Technical State University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Betainized compounds are bioactive metabolites involved in 1-carbon metabolism and cellular osmoprotection. Whole grains (WGs) are important dietary sources of these compounds, but their postprandial and daily metabolic responses in humans remain understudied.

Objectives

To characterize the pharmacokinetic (PK) profiles and short-term accumulation of 16 betainized metabolites following WG wheat and oat intake and to identify WG intake-specific biomarkers.

Methods

Two randomized, controlled crossover trials were conducted. The first was a 2-period PK study involving 12 healthy adults, who consumed WG wheat and oat in a crossover design, with serial plasma and urine collection ≤24 h and 48 h, respectively. The second was a study with five 15-d controlled feeding periods separated by washout phases (∼8 mo total), in which 54 participants consumed wheat- or oat-based diets. Plasma and urine were collected on day 1 (baseline), day 8, and day 15 of each period. All samples were analyzed using liquid chromatography-mass spectrometry (LC-MS). PK parameters were calculated, and statistical analyses evaluated interindividual variability, temporal trends, and grain-specific effects.

Results

Valine betaine, isoleucine betaine, and glutamine betaine exhibited distinct PK profiles, peaking at 5 to 6 h after WG wheat consumption and coinciding with their major urinary excretion window. In the daily grain intake study, valine betaine increased from 1.2 ± 0.4 to 22.2 ± 1.8 nM in plasma and from 39.5 ± 2.2 to 218.5 ± 8.6 μmol/mmol creatinine in urine by day 15 (P < 0.05). Isoleucine betaine showed a similar trend, whereas glutamine betaine was only detected in urine, increasing from 5.7 ± 0.9 to 10.7 ± 0.6 μmol/mmol creatinine. These results demonstrate clear dose- and time-dependent accumulation consistent with their kinetic behavior.

Conclusions

Valine betaine, isoleucine betaine, and glutamine betaine are specific biomarkers of WG wheat intake, not WG oat. Their distinct responses highlight the need for precision nutrition when evaluating the health benefits of WGs. This trial was registered at clinicaltrials.gov as NCT03783637 and NCT04104581.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.